CCL2 and crescentic glomerulonephritis: In a previous report, we reported that administration of an Ang II receptor blocker to rats, a model of crescent-forming glomerulonephritis inducing CD68-positive macrophages and crescent formation following MCP-1 production, attenuated the progression of crescentic glomerulonephritis [12].